Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Yujiro Sato"'
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243379 (2020)
BackgroundB7-H3 is a member of the B7 family of immune-regulatory ligands and is a costimulatory molecule promoting the T cell response in vitro. We herein investigated the clinical utility of serum soluble B7-H3 (sB7-H3) in patients with non-muscle
Externí odkaz:
https://doaj.org/article/7275fae0e67f4fe29227145a484900af
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0199719 (2018)
BACKGROUND:B7-H4 is a member of the B7 family of immune-regulatory ligands and is considered to be a negative regulator of the immune response. We investigated the clinical significance of serum soluble B7-H4 in patients with non-metastatic clear cel
Externí odkaz:
https://doaj.org/article/9454f7b49a594ad29080756d9d1f5154
Publikováno v:
Case Reports in Urology, Vol 2012 (2012)
Several molecular targeted agents have been approved for clinical use for metastatic renal cell carcinoma (mRCC). A case of a 32-year-old woman with mRCC is presented. These tumors could change vascularity by administration of molecular agents. We co
Externí odkaz:
https://doaj.org/article/c39f2afe7126413bb2200c9dcc8bfee2
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243379 (2020)
PLoS ONE
PLoS ONE
Background B7-H3 is a member of the B7 family of immune-regulatory ligands and is a costimulatory molecule promoting the T cell response in vitro. We herein investigated the clinical utility of serum soluble B7-H3 (sB7-H3) in patients with non-muscle
Autor:
Masaya Oshi, Takeshi Azuma, Mitugu Ishizawa, Yasushi Nagase, Yujiro Sato, Akihiro Naito, Akihiko Matsumoto, Keiko Odani, Yukio Homma
Publikováno v:
The Japanese Journal of Urology. 107:34-38
We report a 59-year-old male patient with metastatic small cell carcinoma of the bladder treated with systemic chemotherapy including an amrubicin. The patient was referred to our hospital complaining of macrohematuria. A cytoscopy revealed a non-pap
Autor:
Shingo Miyamoto, Yoshitaka Kinoshita, Yujiro Sato, Akira Ishikawa, Shigenori Kakutani, Akira Hanashi
Publikováno v:
Japanese journal of clinical oncology. 48(6)
Pazopanib (Votrient®) is an oral small-molecule multi-kinase inhibitor that primarily inhibits vascular endothelial growth factor receptor-1, -2 and -3, platelet endothelial growth factor receptor-α, and -β, and the stem-cell factor receptor c-kit
It has previously been demonstrated that the intratumoral generation of the potent androgen dihydrotestosterone (DHT), contributes critically to the progression of prostate cancer and its castration-resistant form, castration-resistant prostate cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9487a487f132d87ae2c01a28a17e6b7c
https://europepmc.org/articles/PMC5769310/
https://europepmc.org/articles/PMC5769310/
Autor:
Yasushi Nagase, Masaya Oshi, Yohsuke Sato, Keiko Odani, Yukihide Matayoshi, Yujiro Sato, Takeshi Azuma
Publikováno v:
Clinical Genitourinary Cancer. 11:337-341
To predict the prognosis, we evaluated the significance of the preoperative neutrophil-lymphocyte ratio (NLR) in patients with upper urinary tract urothelial carcinoma (UUTUC).A cohort of 137 patients diagnosed with UUTUC from 1994 to 2008 at Tokyo M
Publikováno v:
Japanese journal of clinical oncology. 46(10)
OBJECTIVE Our aim was 2-fold: first, to assess the safety of short hydration treatment for urothelial cancer; and second, to assess the resultant quality of life of patients who received the treatment. METHODS We assessed 61 patients including 31 out
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 7, p e0199719 (2018)
PLoS ONE, Vol 13, Iss 7, p e0199719 (2018)
Background B7-H4 is a member of the B7 family of immune-regulatory ligands and is considered to be a negative regulator of the immune response. We investigated the clinical significance of serum soluble B7-H4 in patients with non-metastatic clear cel